Literature DB >> 28374084

Prognosis of Colorectal Cancer in Inflammatory Bowel Disease: Data from a State Registry.

Thomas A Ullman1, Steven H Itzkowitz2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28374084     DOI: 10.1007/s10620-017-4557-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.

Authors:  N Jewel Samadder; Karen Curtin; Thérèse M F Tuohy; Lisa Pappas; Ken Boucher; Dawn Provenzale; Kerry G Rowe; Geraldine P Mineau; Ken Smith; Richard Pimentel; Anne C Kirchhoff; Randall W Burt
Journal:  Gastroenterology       Date:  2014-01-11       Impact factor: 22.682

Review 2.  Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis.

Authors:  C Castaño-Milla; M Chaparro; J P Gisbert
Journal:  Aliment Pharmacol Ther       Date:  2014-04       Impact factor: 8.171

3.  Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.

Authors:  Susan L Gearhart; Hari Nathan; Timothy M Pawlik; Elizabeth Wick; Jonathan Efron; Andrew D Shore
Journal:  Dis Colon Rectum       Date:  2012-03       Impact factor: 4.585

4.  Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.

Authors:  N Jewel Samadder; John F Valentine; Stephen Guthery; Harminder Singh; Charles N Bernstein; Yuan Wan; Jathine Wong; Kenneth Boucher; Lisa Pappas; Kerry Rowe; Mary Bronner; Cornelia M Ulrich; Randall W Burt; Karen Curtin; Ken R Smith
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

5.  Colorectal cancer prognosis among patients with inflammatory bowel disease.

Authors:  Thierry Delaunoit; Paul J Limburg; Richard M Goldberg; James F Lymp; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

  5 in total
  1 in total

1.  Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer.

Authors:  Haiqiang Yao; Jin-Yi Wan; Jinxiang Zeng; Wei-Hua Huang; Clara Sava-Segal; Lingru Li; Xin Niu; Qi Wang; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.